Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
|
|
Xcorporeal, Inc. (XCR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2017 |
GN
| BlackRock® Canada Announces Final Dissolution Proceeds relating to the Termination of Certain iShares Funds |
| 09/27/2017 |
GN
| BlackRock Canada annonce le produit définitif découlant de la dissolution de certains Fonds iShares |
| 04/20/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 04/23/2010 |
25-NSE
| Form 25-NSE - |
| 03/26/2010 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 03/26/2010 |
8-K/A
| Quarterly results |
| 03/25/2010 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi...|
Docs:
|
"Plan of Liquidation and Dissolution of Xcorporeal Operations, Inc",
"Amendment No. 2, to Asset Purchase Agreement, and amended on February 8, 2010",
"Liquidating Trust Agreement, by and among the Xcorporeal, Inc., Xcorporeal Operations, Inc., and XCRLT, LLC, as Trustee",
"Assignment and Assumption of Liabilities and Assets Agreement, by and among Xcorporeal, Inc., Xcorporeal Operations, Inc., and Xcorporeal, Inc. Liquidating Trust" |
|
| 03/23/2010 |
8-K/A
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits |
| 03/19/2010 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Changes in Registrant's Certifyin... |
| 02/12/2010 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/12/2010 |
8-K
| Form 8-K - Current report |
| 12/24/2009 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements |
| 12/18/2009 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Asset Purchase Agreement, by and among Xcorporeal, Inc., Xcorporeal Operations, Inc., National Quality Care, Inc. and Fresenius USA, Inc. * †",
"Stockholder Voting Agreement, by and among Fresenius USA, Inc. and the stockholders of Xcorporeal, Inc. identified on Schedule A attached thereto.",
"Agreement, by and between Xcorporeal, Inc. and Fresenius USA, Inc. * †",
"XCORPOREAL ANNOUNCES SIGNING AGREEMENT FOR THE SALE OF SUBSTANTIALLY ALL OF ITS ASSETS" |
|
| 11/16/2009 |
10-Q
| Quarterly Report for the period ended September 30, 2009 |
| 09/10/2009 |
8-K
| Form 8-K - Current report |
| 08/26/2009 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 08/13/2009 |
10-Q
| Quarterly Report for the period ended June 30, 2009 |
| 05/21/2009 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 05/15/2009 |
10-Q
| Quarterly Report for the period ended March 31, 2009 |
| 04/16/2009 |
8-K
| Form 8-K -- Current report |
| 03/31/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
| 03/16/2009 |
8-K
| Form 8-K -- Current report |
| 03/06/2009 |
8-K
| Form 8-K -- Current report |
| 02/10/2009 |
PRER14A
| Form PRER14A -- Preliminary Proxy Soliciting materials |
| 02/05/2009 |
8-K
| Form 8-K -- Current report |
| 12/03/2008 |
PRER14A
| Form PRER14A -- Preliminary Proxy Soliciting materials |
| 11/19/2008 |
10-Q
| Quarterly Report for the period ended September 30, 2008 |
| 10/08/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/08/2008 |
8-K
| Form 8-K -- Current report |
| 09/09/2008 |
4
| Goldberger Daniel S (CEO) has filed a Form 4 on Xcorporeal, Inc.|
Txns:
| Disposed of 200,000 options to buy
@ $5, valued at
$1M
|
|
| 08/15/2008 |
4
| TANG WILSON (Former Chief Operating Officer) has filed a Form 4 on Xcorporeal, Inc. |
| 08/14/2008 |
10-Q
| Quarterly Report for the period ended June 30, 2008 |
| 08/01/2008 |
10-Q/A
| Quarterly Report for the period ended March 31, 2008 [amend] |
| 07/03/2008 |
4
| PELED NINA (Former Senior V.P) has filed a Form 4 on Xcorporeal, Inc. |
|
|
|